RankingsPricing
  1. JP-listed companies
  2. Oncolys BioPharma Inc.
  3. Financials
  4. Income before tax

Oncolys BioPharma Inc.【JP:4588】

Market cap
¥37.9B
P/E ratio
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndIncome before tax (Million JPY)YoY (%)
Dec 31, 2024-1,664-13.06%
Dec 31, 2023-1,914+64.56%
Dec 31, 2022-1,163-22.51%
Dec 31, 2021-1,501-12.92%
Dec 31, 2020-1,724+219.66%
Dec 31, 2019-539-56.17%
Dec 31, 2018-1,230+13.15%
Dec 31, 2017-1,087+25.80%
Dec 31, 2016-864+1.12%
Dec 31, 2015-855+17.71%
Dec 31, 2014-726+16.12%
Dec 31, 2013-625+532.83%
Dec 31, 2012-99+1599.81%
Dec 31, 2011-6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)